Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine versus placebo for respiratory parameters in mechanically ventilated ICU patients
IRCT20240929063203N10Phase 3Recruiting
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in respiratory failure comparing Caffeine with Placebo (2 arms). Primary endpoints: Static lung compliance, Dynamic lung compliance and 2 more. Started Jul 2026; status: recruiting.
02
Drugs
caffeine
03
Conditions
respiratory failure
Beyond the preview
Go deeper on IRCT20240929063203N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240929063203N10.